SPC-TNF transgenic mice, a variant generated by Dr. Vasalli in 1995, were used, and transgenic TNF on the SPC promoter was overexpressed only in lung tissue and consequently resulted in alveolitis, alveolar disruption, and subsequent fibrogenesis in lung tissue [51]. Here, TNF is linked to hypersensitivity pneumonitis.